EU regulator conditionally approves Abbott's purchase of St Jude
- Wall Street surges to new highs; transports set record
- lululemon athletica (LULU) Tops Q3 EPS by 4c; Adj.-Comps Outpaced Views
- Abbott (ABT) Files Complaint to Terminate Alere (ALR) Acquisition
- Costco Wholesale (COST) Tops Q1 EPS by 5c; Comps Up 1%, 2% Ex-Gas
- After-Hours Stock Movers 12/07: (VYGR) (LULU) (HRB( Higher; (OHRP) (VRNT) (CMTL) Lower (more...)
The ticker and trading information for St. Jude Medical is displayed where the stock is traded on the floor of the New York Stock Exchange (NYSE) in New York City, U.S., April 28, 2016. REUTERS/Brendan McDermid/File Photo
Get inside Wall Street with StreetInsider Premium. Claim your 2-week free trial here.
BRUSSELS (Reuters) - The European Commission on Wednesday said it has given its conditional approval to U.S. medical device maker Abbott Laboratories' (NYSE: ABT) bid for peer St Jude Medical Inc (NYSE: STJ).
Reuters reported on Nov. 15 that the $25 billion deal was going to be cleared in Brussels.
The European Commission, the mergers regulator, said in a statement that its approval was conditional on "Abbott divesting two devices used in cardiovascular treatments."
(Reporting by Gabriela Baczynska)
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Abbott (NYSE: ABT) weekly volatility elevated, into seeking to terminate acquisition of Alere
- ThyssenKrupp secrets stolen in 'massive' cyber attack this year
- Exclusive: Risking Beijing's ire, Vietnam begins dredging on South China Sea reef
Create E-mail Alert Related CategoriesReuters
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!